Nephrolithiasis
📧 Sign up to get email alerts when something new happens for Nephrolithiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-09Clinical Trial Update: Trial of Efficacy of the RetroPerc Device [NA]
The clinical trial evaluating the RetroPerc device for nephrolithiasis (kidney stones) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-13Clinical Trial Update: The RELIEF™ Ureteral Stent Randomized Controlled Trial [NA]
The RELIEF ureteral stent randomized controlled trial (NCT06720740) sponsored by UC San Diego for nephrolithiasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-26Clinical Trial Update: Effect of Virtual Glasses on Pain and Comfort During ESWL [NA]
A clinical trial evaluating whether virtual glasses can reduce pain and improve comfort during extracorporeal shock wave lithotripsy has bee…
-
CLINICAL_TRIALS withdrawal · 2025-06-10Clinical Trial Update: The Interplay Between Oxalate, Immunity and Infection [NA]
The clinical trial NCT04605055 evaluating the interplay between oxalate, immunity, and infection in relation to kidney stones has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-04-04Clinical Trial Update: A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. [NA]
The trial comparing a disposable flexible cystoscope with reusable scopes in adult patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-07-09Clinical Trial Update: Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS [NA]
The clinical trial evaluating microperc versus flexible ureteroscopy (FURS) for lower pole nephrolithiasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-11Clinical Trial Update: A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria [Phase 1]
BioMarin's BMN-255 Phase 1 trial in hyperoxaluria with nonalcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy [Phase 3]
A Phase 3 trial comparing silodosin versus tamsulosin for stone clearance after extracorporeal shock wave lithotripsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-09Clinical Trial Update: The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary Calcium [Phase 2, Phase 3]
Brigham and Women's Hospital's Phase 2/3 trial investigating the effect of vitamin D on urinary calcium excretion in kidney stone formers ha…
-
CLINICAL_TRIALS withdrawal · 2017-01-05Clinical Trial Update: A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria [Phase 2]
A Phase 2 trial investigating pyridoxamine to reduce urine oxalate in people with nephrolithiasis or hyperoxaluria has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Potassium Citrate Supplementation vs. Dietary Counseling [Phase 2]
A Phase 2 clinical trial evaluating potassium citrate supplementation versus dietary counseling for nephrolithiasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: International Registry for Primary Hyperoxaluria
The International Registry for Primary Hyperoxaluria, sponsored by Mayo Clinic, has been withdrawn from clinical trials.